PEOPLE - Deltex Medical (UK) makes appointment:
This article was originally published in Clinica
Haemodynamic monitoring company Deltex Medical (Chichester, UK) has elected former UK NHS CEO Duncan Kirkbride Nichol to its board, as a non-executive director. Sir Duncan worked for the NHS for nearly 30 years in various senior management roles, and is also currently non-executive director of Synergy Healthcare. He also held the same position for the UK-based private hospital group BUPA, from 1994 until 2002.
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.